Alternatives to Mayo Clinic Ventures

The innovation, commercialization, and venture capital arm of UPMC.

Transforms smartphone cameras into medical devices for home urinalysis and digitized wound care.

Cloud platform for secure sharing and analysis of real-world health data for life sciences.

AI-powered platform for streamlining medical equipment procurement in home care.

EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.

Mon4t develops smartphone-based medical tests for neurological disorders, providing real-time monitoring and feedback to patients and physicians.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

A mental health platform connecting individuals with licensed therapists and psychiatric providers, offering digital tools for matching, scheduling, and practice management.

Virta Health offers a digital therapeutic for reversing type 2 diabetes and other chronic metabolic conditions.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Digital physical therapy and recovery platform using everyday sensors for ongoing health diagnostics.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Connects patients, providers, pharmacies, and life science companies to improve treatment affordability.

TytoCare provides a Home Smart Clinic solution enabling accessible, high-quality primary care from home through remote physical exams.

AI Care Manager for empathetic, scalable patient engagement in healthcare.

Digital leader in preventive heart health using connected devices and AI coaching.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.